Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles by Kah, James Chen Yong et al.
© 2007 Dove Medical Press Limited.   All rights reserved
International Journal of Nanomedicine 2007:2(4) 785–798 785
ORIGINAL RESEARCH
Early diagnosis of oral cancer based on the 
surface plasmon resonance of gold nanoparticles
James Chen Yong Kah1
Kiang Wei Kho2
Caroline Guat Leng Lee2
Colin James Richard
Sheppard1
Ze Xiang Shen3
Khee Chee Soo2
Malini Carolene Olivo2
1Division of Bioengineering, National 
University of Singapore, Singapore; 
2Division of Medical Sciences, 
National Cancer Centre Singapore, 
Singapore; 3School of Physical and 
Mathematical Sciences, Nanyang 
Technological University, Singapore
Correspondence: Malini Carolene Olivo
Division of Medical Sciences, National 
Cancer Centre Singapore, 11 Hospital 
Drive, Singapore 169610
Tel +65 64368317
Fax +65 63720161
Email dmsmcd@nccs.com.sg
Abstract: The high mortality rate in cancer such as oral squamous cell carcinoma is commonly 
attributed to the difﬁ  culties in detecting the disease at an early treatable stage. In this study, we 
exploited the ability of gold nanoparticles to undergo coupled surface plasmon resonance and set 
up strong electric ﬁ  elds when closely-spaced to improve the molecular contrast signal in reﬂ  ec-
tance-based imaging and also to enhance the Raman signal of bioanalytes in cancer. Colloidal 
gold nanoparticles were synthesized and conjugated to anti-epidermal growth factor receptor 
(EGFR) for imaging. A self-assembled surface enhanced Raman scattering (SERS)-active gold 
nanoparticle monolayer ﬁ  lm was also developed as a biosensing surface using a simple drop-dry 
approach. We have shown that gold nanoparticles could elicit an optical contrast to discriminate 
between cancerous and normal cells and their conjugation with antibodies allowed them to map the 
expression of relevant biomarkers for molecular imaging under confocal reﬂ  ectance microscopy. 
We have also shown that the SERS spectra of saliva from the closely-packed gold nanoparticles 
ﬁ  lms was differentiable between those acquired from normal individuals and oral cancer patients, 
thus showing promise of a simple SERS-based saliva assay for early diagnosis of oral cancer.
Keywords: Gold nanoparticles, reﬂ  ectance imaging, confocal microscopy, epithelial carcinoma, 
epidermal growth factor receptor, coupled surface plasmon resonance, oral cancer, surface 
enhanced Raman scattering
Introduction
Oral squamous cell carcinoma is the sixth most common cancer for both sexes world-
wide. The 5-year survival rate of the disea0se is currently about 50%. Oral cancer 
is often diagnosed only after it has advanced to an untreatable stage (Spafford et al 
2001; Zheng et al 2002) where the cancer cells have become aggressive and immune 
to therapeutic drugs. Detecting oral cancer at its earliest is thus vital for improving 
the survival rate of this disease. Current clinical diagnosis of most epithelial cancers, 
including oral cancer, typically involves performing invasive needle biopsies fol-
lowed by histological examination on the excised tissue. The procedure may present 
psychological trauma and risk of infection to patients. Furthermore, biopsy is usually 
performed only under the condition that the lesions are spotted and appear abnormal 
(Lumerman et al 1995). Yet, pre-cancerous lesions can appear innocuous or occur 
in hidden sites such as the crypts in the base of tongue, and can therefore easily go 
undetected even with white-light endoscopy (Spafford et al 2001). Furthermore, 
conventional histopathological diagnosis is based on morphological and structural 
changes at the cellular or tissue level, which may not be obvious for early-stage tumors 
(Wickline and Lanza 2000). Taken together, it is clear that a diagnostic method for 
detecting early stage oral cancer is highly desired.
Recently, an increased amount of efforts has been made to develop less-invasive 
early diagnostic modalities for oral cancer, of which the in vivo high resolution imag-
ing of oral epithelial tissues using novel optical systems (Sokolov, Aaron et al 2003) International Journal of Nanomedicine 2007:2(4) 786
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and the chemical analysis of saliva (Chen et al 2002) hold 
great promises as valuable tools. However, these techniques 
are met with several limitations to their effective use as diag-
nostic tools. Although advanced optical systems for in vivo 
imaging such as optical coherence tomography (OCT) and 
confocal reﬂ  ectance endomicroscopy are designed to image 
cell and stromal morphology for non-invasive clinical diag-
nosis in real time, the contrast between neoplastic and normal 
tissues is often too low to be of any clinical value (Wickline 
and Lanza 2002). Furthermore, these structural-based 
imaging techniques are unable to image the biomolecular 
changes associated with carcinogenesis in vivo (Koenig et al 
2001) due to their inherent optical conﬁ  gurations, which can 
provide earlier and more accurate diagnosis for suspicious 
pre-cancerous lesions as compared to their structural and 
morphological changes.
Although these biomolecular changes can potentially be 
detected through non-invasive quantitative assessment of 
the chemical compositions of saliva (Chen et al 2002) using 
techniques such as enzyme-linked immunosorbent assay 
(ELISA), micro-satellite analysis and high performance 
liquid chromatography (HPLC), these highly speciﬁ  c tech-
niques in molecular detection are usually labor-intensive 
procedures and requires long analysis time. Even as this can 
be overcome substantially using mass spectrometry (MS), 
which normally gives a shorter analysis time and higher 
sensitivity, a clinically reliable MS data for saliva specimens 
is unfortunately hard to come by because issues such as 
ion-suppression effect, non-universal ionization efﬁ  ciency, 
and machine-to-machine variations, have complicated MS 
analysis of such complex sample as saliva (Li et al 2001). 
Furthermore, these techniques have yet to discover reliable 
and well-validated markers for oral cancer. Raman spectros-
copy is another technique that has long been used to study 
cancer-related chemical changes in both cancerous tissues 
as well as bio-ﬂ  uids. For instance, Li et al has shown that 
the Raman spectra of sera collected from normal individuals 
and cancer patients are different in more than 80% of cases 
for various cancers (Li et al 2001). However, the Raman 
signals from these biologic samples are usually weak and 
not sensitive enough to merit clinical value.
Gold nanoparticles have recently been investigated to 
address the limitations of these imaging and chemical-based 
diagnostic techniques based on their optical properties. These 
metallic nanoparticles exhibit unique optical response to light 
which allow them to resonantly scatter light when excited at 
their surface plasmon resonance frequency (Mulvaney 1996). 
Furthermore, the scattering cross section per particle is 
increased when the gold nanoparticles aggregate to produce 
an even larger optical signal (Sokolov, Follen et al 2003). 
This mode of enhanced scattering from coupled surface 
plasmon resonances of aggregated gold nanoparticles can be 
exploited to provide good optical contrast if the gold nanopar-
ticles can be brought close together in cellular environment 
under the inﬂ  uence of biochemical processes associated with 
disease pathology. As such, gold nanoparticles show poten-
tial as optical probes for reﬂ  ectance-based optical imaging 
to address their limitation in providing contrast for early 
biomolecular signatures present in cells and tissue (Schultz 
et al 2000; Sokolov, Follen et al 2003; El-Sayed et al 2005). 
Furthermore, when the gold nanoparticles are closely-packed 
to form a ﬁ  lm, they are also capable of undergoing plasmon 
resonance with the laser excitation wavelength to generate 
strong excitation ﬁ  elds on the ﬁ  lm surface and this can be 
used to improve the sensitivity of optical based Raman spec-
troscopy for the chemical analysis of diluted ﬂ  uid analytes 
such as saliva specimen applied on its surface.
Gold nanoparticles also possess other favorable physi-
cochemical properties for use as optical probes for early 
diagnostics. They can be easily conjugated to antibodies or 
peptides through electrostatic charge interaction or coordi-
nate bonding to probe for speciﬁ  c cellular biomarkers with 
high speciﬁ  city and afﬁ  nity (Geoghegan and Ackerman 
1977). When coupled with appropriate biomarkers, these 
gold nanoparticles bioconjugates may provide useful optical 
signal for molecular speciﬁ  c information to assist clinicians in 
diagnosis of pre-cancers. Gold nanoparticles are also gener-
ally biocompatible and benign in biological tissues and have 
been applied for clinical treatment of other disease conditions 
such as rheumatoid arthritis (Abrams and Murrer 1993).
In this study, our objectives were to develop colloidal 
gold nanoparticles as well as a self-assembled monolayer 
of these nanoparticles and exploit their ability to undergo 
coupled surface plasmon resonance and set up strong elec-
tric ﬁ  elds when closely-spaced for cancer diagnosis using 
both an imaging and chemical approach. Under the imaging 
approach, we demonstrated the use of these nanoparticles as 
an optical contrast agent for improving the optical contrast of 
clinically relevant biomarkers in epithelial cancer cells under 
reﬂ  ectance-mode imaging in vitro. The epidermal growth 
factor receptor (EGFR) is one such clinically relevant cell 
surface receptor biomarker used in this study that is overex-
pressed in vast majority of epithelial cancer but not in normal 
cells (Eisbruch et al 1987; Shin et al 1994; Ke et al 1998; 
Nouri et al 2000). Under the chemical approach, we demon-
strated the use of gold nanoparticles in surface enhanced Ra-International Journal of Nanomedicine 2007:2(4) 787
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man scattering (SERS) to enhance the Raman spectroscopy 
signal for the analysis of cancer-related chemical changes in 
saliva. We developed a simple and cost-effective method for 
preparing highly sensitive SERS-based saliva assay based on 
SERS-active gold nanoparticle ﬁ  lms and used it to collect 
and analyze spectroscopically, the SERS from the sample-
ﬁ  lm interface to seek for spectral features indicative of oral 
cancer. The use of saliva as a diagnostic ﬂ  uid would offer a 
few advantages over previous sera-based counterparts in that 
saliva is easily accessible, painlessly acquired and presents 
lower risk of infection compared to serum.
Materials and methods
Synthesis and characterization of gold 
nanoparticles
Colloidal gold nanoparticles were synthesized by the reduc-
tion of 0.259 mM of hydrogen tetrachloroaurate (Sigma-
Aldrich) by 34 mM of trisodium citrate (Sigma-Aldrich) at 
temperature of 90 °C (Hayat 1989). The particle size was 
determined by transmission electron microscopy (TEM) 
(Jeol JEM-1010 100 kV) to show uniform spherical and 
monodisperse gold nanoparticles with an average diameter 
of 15 nm. Their UV-Vis extinction spectrum was character-
ized using a UV-Vis spectrophotometer (Shimadzu UV-2401 
PC). The side-scatter spectrum of the gold nanoparticles was 
characterized using a USB2000 miniature ﬁ  ber optic spectro-
photometer (Ocean Optics, Inc) by illuminating the colloidal 
sample and detecting the spectrum at 90° to the incident 
illumination. The concentration of the gold nanoparticles in 
the colloid was characterized against known gold hydrosol 
standards from British Biocell International Ltd (EMGC.15, 
particle concentration = 1.4 × 1012 particles per ml) and was 
determined to be approximately 1.23 × 1012 particles per ml. 
This colloid was stored at 4 °C when not used.
SERS substrate preparation
and characterization
SuperFrost®Plus microscope glass slides (VWR Scientiﬁ  c) 
were rinsed thoroughly with 70% v/v aqueous solution of 
ethanol (Merck) for 1 minute. The slides were then rinsed 
four times to remove traces of ethanol with fresh distilled 
water (18 MΩ, obtained from Millipore Mili-Q water puri-
ﬁ  cation system) each time. The slides were stored in water 
until needed. To fabricate a gold particle ﬁ  lm, a 150-μl 
droplet of gold nanoparticles was pipetted onto the surface 
of a cleaned slide. The slide was then dried in a dessicator 
for 24 h, followed by rinsing in distilled water, after which 
the slides were dried with a dust blower. All of the prepared 
gold colloid ﬁ  lms were kept in distilled water until needed.
Optical transmission measurements of the resultant gold 
colloid ﬁ  lms were performed using a Shimadzu UV-2401 
PC monochromator system. A cleaned SuperFrost®Plus 
microscope slide was used as the reference sample. Each 
slide bearing a gold ﬁ  lm was placed in the illumination 
light path and secured with blue-tack. The light beam was 
passing through the slide perpendicularly. Care was taken to 
ensure that the blue-tack was not in the light path. Atomic 
force microscopy (AFM) measurements were performed 
under ambient conditions using a Digital Instrument DI3000 
Nanoscope III in tapping mode (247.9 KHz) with a typical 
resolution of about 5 to 15 nm, and a horizontal scanning 
rate of 1 Hz.
Conjugation of gold nanoparticles
with anti-EGFR
The gold nanoparticles were conjugated to monoclonal anti-
EGFR (Santa Cruz Biotechnology Inc.) as our selected cancer 
biomarker for imaging via established protocols for passive 
absorption of anti-EGFR on the surface of gold nanopar-
ticles. Brieﬂ  y, the conjugation was performed by incubating 
the gold nanoparticles with anti-EGFR for about 10 mins 
at room temperature as according to a modiﬁ  ed procedure 
reported previously (Geoghegan and Ackerman 1977). The 
successful conjugation of antibodies on gold nanoparticles 
was ascertained by addition of 10% common salt solution and 
observing any visible color change in the colloidal solution. 
The presence of salt caused unconjugated gold nanoparticles 
to aggregate and result in a visible color change from red 
to purple or gray. After the 10 minutes of incubation time, 
the anti-EGFR conjugated gold nanoparticles were washed 
and resuspended in 1X PBS buffer (pH 7.4) containing 5% 
bovine serum albumin (BSA) (Sigma Aldrich, Inc) and stored 
at 4 °C. Spectrophotometry was performed using the same 
Shimadzu UV-2401 PC monochromator system to conﬁ  rm 
conjugation of anti-EGFR to gold nanoparticles. The gold 
nanoparticles were also conjugated to BSA, a non-cellular 
binding protein, as negative control probes using the same 
procedures as above.
Cellular imaging
Both the poorly-differentiated nasopharyngeal epithelium 
carcinoma CNE2 cell line and the normal human lung 
ﬁ  broblast (NHLF) cell line were used in this study. The 
CNE2 cells were grown in RPMI 1640 supplemented with 
10% fetal bovine serum, 2 mM glutamine, sodium pyruvate, International Journal of Nanomedicine 2007:2(4) 788
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non-essential amino acids and 100 unit/ml penicillin/strepto-
mycin while the normal cells were grown in ﬁ  broblast growth 
medium (Cambrex Corp.). Both cell lines were grown and 
maintained at 37 oC in humidiﬁ  ed 5% CO2 and 95% air at-
mosphere. Prior to imaging, both cell lines were trypsinized 
and ﬁ  xed in 2% paraformaldehyde before incubating them 
with the anti-EGFR conjugated gold nanoparticles for 2 h at 
37 °C. The cells were also incubated with BSA conjugated 
gold nanoparticles as a negative control for the antibody 
binding. Following the incubation, the cells were rinsed 
thrice with PBS to wash away the excess and unbounded 
gold bioconjugates and were then placed on a microscope 
slide for imaging. Imaging was performed using a confocal 
microscopy (LSM510 Meta, Carl Zeiss) in the reﬂ  ectance 
mode with a 20X olympus objective under 633 nm excitation 
with a helium-neon laser.
Preparation of saliva samples
Saliva samples were collected from 5 normal healthy indi-
viduals and 5 oral-cancer patients following their informed 
consent. This study was reviewed and approved by the Ethics 
Committee of the National Cancer Centre Singapore. Each 
subject was asked to rinse their mouth thoroughly with 
water for 30 min to remove any food particles in their oral 
environment, before expelling saliva into a 15 ml plastic 
container (Nalgene, Eppendorf). About 1 ml of whole saliva 
was obtained each time. The specimen was then transferred 
into a 1.5 ml Eppendorf centrifuge tube and spun, using the 
Eppendorf Centrifuge 5415C, at 14,000 rpm for 5 min to 
remove small particulates and exfoliated cells. The superna-
tant was then extracted and stored in a new centrifuge tube 
at –20 °C until needed. Note that only samples with no sign 
of blood contamination are used for the experiment.
SERS measurements
The Raman experiments were carried out with a modiﬁ  ed 
micro-Raman system, in which an Olympus microscope 
with a color closed circuit television (CCTV) system was 
coupled to a Spex 1704 spectrometer that was equipped 
with a liquid nitrogen cooled CCD detector. In this modiﬁ  ed 
system, the coupling optics was arranged in a box that was 
linked to the modiﬁ  ed optical microscope by a mechanical 
arm and ﬁ  xed to the Spex spectrometer. The laser light at 
632.8 nm was introduced from the back of the box, after 
passing through a plasma ﬁ  lter and was then directed into 
the modiﬁ  ed microscope via a notch ﬁ  lter. This notch ﬁ  lter 
acted as a reﬂ  ection mirror to the laser light, but to the signal 
returning from the sample, it was a very effective ﬁ  lter to the 
Rayleigh (laser) line. This ﬁ  lter prevented any backscattered 
laser from entering the spectrometer, and hence from inter-
fering with the Raman signals to be collected, but allowed 
Raman signals to transmit with little attenuation. The returned 
signals then passed through a second notch ﬁ  lter which was 
used to further improve the Rayleigh rejection. The Raman 
signal was then focused onto the entrance slit of the Spex 
spectrometer by a coated singlet focusing lens of 50 mm 
focal length. The inclusion of the CCTV system allowed both 
the laser beam and white light to be viewed directly from 
the monitor. A biological specimen could also be viewed 
directly from the monitor. The objective lens used in this 
study was from Olympus with magniﬁ  cation 10 × and NA 
0.25. The closely-packed gold particle ﬁ  lm was ﬁ  rst coated 
with a drop (approximately 30 μl) of saliva. Immediately, a 
633 nm laser was focused, via a 10 × NA 0.25 objective, onto 
the sample-ﬁ  lm interface. Laser intensity at sample is about 
2 mW. Spectrum acquisition was then started immediately. 
The spectral resolution was 1 cm–1 and an integration time 
of 10 s was used for all Raman measurements.
Results
The extinction and side-scatter spectrum of the gold 
nanoparticles is shown in Figure 1. The extinction spec-
trum (Figure 1a) shows a sharp peak at 520 nm which 
corresponds to the surface plasmon resonance typical of 
gold nanoparticles of that size (Murillo et al 2002). The 
side-scatter spectrum (Figure 1b) shows that the gold 
nanoparticles have the potential to scatter light strongly 
at around 600 nm. Since the light scattering of biological 
tissue in this wavelength range is small compared to the 
light scattering afforded by gold nanoparticles (Taroni et al 
2003), the presence of the gold nanoparticles in tissue may 
be distinguishable from the scattering intensity. Spectro-
photometry was used to conﬁ  rm the conjugation of anti-
EGFR to gold nanoparticles. The extinction spectrum of 
the gold nanoparticles both before and after conjugation 
with anti-EGFR was measured and is shown in Figure 2. 
The UV-Visible extinction spectrum shows a characteristic 
red-shift (≈6 nm) of the peak of the surface plasmon reso-
nance which is typical of protein binding on the surface 
of the gold nanoparticles. This indicates the successful 
conjugation of anti-EGFR on the gold nanoparticles. An 
additional indication of anti-EGFR binding to the surface 
of the nanoparticles is their stability in 10% common salt 
solution where the gold bioconjugates did not aggregate to 
result in a color change after the addition of salt solution. 
The reduction in the intensity of the peak after conjugation International Journal of Nanomedicine 2007:2(4) 789
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could be due to the loss in some gold nanoshells during the 
washing steps after conjugation.
The ability of gold nanoparticles to increase the opti-
cal scattering of cells when attached to their surface was 
investigated by labeling the cells with these nanoparticles 
and observing them under confocal reﬂ  ectance microscopy. 
Figure 3 shows the confocal reﬂ  ectance images of CNE2 cells 
before and after labeling with anti-EGFR conjugated gold 
nanoparticles, as well as CNE2 cells labeled with our control 
of BSA conjugated gold nanoparticles which are not known 
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Figure 1 (a) Extinction spectrum of synthesized 15 nm gold nanoparticles with a peak plasmon resonance wavelength of 520 nm and (b) their side-scatter spectrum 
showing a peak reﬂ  ectance of the gold nanoparticles at around 600 nm.International Journal of Nanomedicine 2007:2(4) 790
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to exhibit high binding afﬁ  nity to the cells. A signiﬁ  cant 
increase in the reﬂ  ectance signal was observed in the cells 
labeled with the antibody conjugated gold nanoparticles 
compared to the other two controls, where the reﬂ  ectance 
signal seemed to be non-speciﬁ  c and at random and could 
barely be resolved from the dark background. The increase 
in reﬂ  ectance signal that arose from the bright scattering ring 
formed could be attributed to the localization of the gold 
nanoparticles on the cell membrane as it was not observed 
in the unlabeled cells.
In addition to increasing the optical scattering on cells, 
the anti-EGFR conjugated gold nanoparticles also exhibited 
speciﬁ  city in binding to cancer cells overexpressing EGFR 
compared to normal cells. The labeling of anti-EGFR gold 
nanoparticles on both CNE2 and NHLF cells under confo-
cal reﬂ  ectance microscopy is shown on Figure 4 together 
with their corresponding autoﬂ  uorescence image. The au-
toﬂ  uorescence images of the two cell lines show similar 
autofluorescence level. However, the overexpression of 
transmembrane EGFR in CNE2 cells caused more anti-EGFR 
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Figure 2 Changes in extinction spectrum of gold nanoparticles after conjugation with anti-EGFR to demonstrate the binding of anti-EGFR on gold nanoparticles. Spectrum 
after conjugation is shown in dashed line.
Figure 3 Confocal reﬂ  ectance images of CNE2 cells (a) before labeling, (b) after labeling with our control BSA conjugated gold nanoparticles and (c) after labeling with 
anti-EGFR conjugated gold nanoparticles. Images are cross-sectional slices of cells taken at the mid-focal plane at 20X magniﬁ  cation. False-color reﬂ  ectance images obtained 
at excitation 633 nm. Scale bar in all images is 20 μm.International Journal of Nanomedicine 2007:2(4) 791
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gold nanoparticles to be selectively localized around the 
cytoplasmic membrane of the CNE2 cell compared to the 
nominal EGFR expression in normal NHLF cells, resulting 
in signiﬁ  cantly higher reﬂ  ectance intensity. The reﬂ  ectance 
intensity of the CNE2 cells is about 30 times higher than 
that of the NHLF cells, sufﬁ  cient to elicit an optical contrast 
between them for discriminating the cancerous against non-
cancerous cells. As the regions of increased reﬂ  ectance due 
to the presence of gold nanoparticles correspond to regions 
of high EGFR expression, this strong reﬂ  ectance signal could 
provide a map of EGFR expression under confocal reﬂ  ectance 
microscopy.
One of the objectives of this study was also to develop a 
simple and cost effective method for preparing SERS-active 
substrates which exploits the surface plasmon resonance of 
gold nanoparticles to enhance the Raman signal of bioana-
lytes. In particular, we looked at the fabrication of arrays con-
sisting of closely spaced but non-aggregated monodisperse 
A B
D C
Figure 4 Autoﬂ  uorescence image of (a) NHLF and (b) CNE2 cells. Their corresponding confocal reﬂ  ectance images after labeling the (c) NHLF and (d) CNE2 cells with 
anti-EGFR gold nanoparticles is shown below the autoﬂ  uorescence image. Images are cross-sectional slices of cells taken at the mid-focal plane at 20X magniﬁ  cation. False-
color ﬂ  uorescence images obtained at excitation 488 nm and reﬂ  ectance images obtained at excitation 633 nm. Scale bar in all images is 20 μm.International Journal of Nanomedicine 2007:2(4) 792
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nanoparticles, since it has been established by many previous 
studies that such an array could generate large SERS-activity 
(Katherine et al 1995). The large enhancement is derived 
mainly from the crevices between two adjacent particles, in 
which trapped analyte molecules experience enhanced elec-
tromagnetic ﬁ  eld due to coupled surface plasmon resonance 
(Katherine et al 1995). Unfortunately, current techniques for 
preparing closely-spaced particle arrays are either too labour-
intensive or too costly to scale up. As such, we have devel-
oped a simple alternative approach in which closely-packed 
arrays of metallic nanoparticle ﬁ  lms were fabricated using a 
simple drop-dry approach. Figure 5 shows a SuperFrost®Plus 
microscope slide bearing three colloid ﬁ  lms deposited by 
drying three 150-μl drops of gold nanoparticles containing 
1.4 × 1012 particles per ml as delineated above. Each ﬁ  lm is 
about 10 to 12 mm in diameter. Further observations under 
a microscope revealed interesting deposition pattern (see 
Figure 5b). Basically, three types of structures could be 
observed: a ring at the perimeter, a continuous layer (white 
arrow) and an unevenly coated region (dark arrow).
A representative UV-Vis spectrum of the gold nanoparticles 
ﬁ  lm is shown in Figure 6, along with that of the gold nanopar-
ticles colloid for comparison. One can immediately notice a 
double-peak feature in the ﬁ  lm’s spectrum (see curve A), which 
is an indication of a closely-packed but non-aggregated morphol-
ogy, according to a previous computer simulation (Sanchez-Gil 
et al 2002). The ﬁ  rst resonance peak in curve A situated at 
about 520 nm can be attributed to the plasmon resonance in the 
individual gold nanoparticles. The second peak located at 633 
nm is derived from the collective plasmon oscillation among 
the closely-packed particles (Katherine et al 1995). Further 
analysis of the surface morphology was obtained from the AFM 
mapping of the uniformly coated regions. The result is shown 
in Figure 7. Analysis of the height proﬁ  le revealed that the ﬁ  lm 
was generally monolayer thick, with a small percentage of the 
total area being two- to three- particles thick.
Saliva samples were collected from 5 normal healthy 
individuals and 5 oral-cancer patients. Typical SERS spectra 
for these samples are shown in Figure 8. Tentative assignment 
of the major vibrational bands in the spectra based on existing 
knowledge is presented in Table 1. One of the differences 
between these spectra is the occurrence of Raman peaks at 
670, 1097, and 1627 cm–1 in the abnormal-saliva spectrum 
(see bottom spectrum).
Discussion
The results of our study have demonstrated the exploita-
tion of surface plasmon resonance of gold nanoparticles in 
performing cancer diagnosis through an imaging and a chemi-
cal analysis approach. We have synthesized and characterized 
the optical properties of 15 nm gold nanoparticles. The gold 
nanoparticles were conjugated to monoclonal anti-EGFR 
via passive absorption of the antibodies onto its surface and 
allowed to interact with cancer cells. The 6 nm red-shift in 
the peak surface plasmon resonance of the gold nanopar-
ticles after conjugation with the antibody is associated with 
alterations in the local refractive index and hence dielectric 
constant around the surface of the gold nanoparticles particles 
due to the presence of a layer of antibodies around its surface. 
The change in dielectric constant affects the light scattering 
properties of gold nanoparticles according to the Mie theory 
(Bohren and Huffman 1983). This red-shift is typical of 
protein binding on the surface of the gold nanoparticles and 
serves as an indication of the presence of the antibodies on 
the surface of the gold nanoparticles.
The results of our in vitro experiments with the CNE2 
cells have demonstrated that the anti-EGFR gold nanopar-
ticles could serve as a potential optical contrast agent to 
increase the detection visibility of cells under reﬂ  ectance-
based imaging systems. The anti-EGFR were able to 
target and bind to the extracellular domain of EGFR on 
the cellular membrane even after conjugation to the gold 
nanoparticles. This means that the anti-EGFR still retains 
its antigen binding sites and activity after conjugation. The 
localization of the anti-EGFR gold nanoparticles forms 
highly reﬂ  ective beacons due to the strong resonant light 
scattering response of gold nanoparticles on the cell surface 
to the excitation light. This resonant scattering condition is 
further enhanced when the gold nanoparticles cluster close 
together on the cell membrane as they attach to their recep-
tor and their surface plasmon interacts with each other. This 
Table 1 Assignments of major vibrational bands in the SERS 
spectra of saliva samples
Observed raman shifts (cm–1)pp Possible  assignments
Normal Cancerous 
432 432 Skeletal  bending
493 – 
612 – 
– 670  υ (C–S)
709 –  υ (C–S) Met
– 1097  υ (C–N)
1114 –  υ (C–C)
1269 1269 δ (=CH) Phospholipid
–  1627  Trp, Tyr and Phe
1666–1700 1666–1700 Protein  (Amide  I):  α -helix, 
  β -sheet, random-coilInternational Journal of Nanomedicine 2007:2(4) 793
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A
10 mm
1 mm
B
Figure 5 Macroscopic and microscopic images of colloid ﬁ  lms by drying 150 μl of 15 nm gold nanoparticles on a SuperFrost®Plus microscope slide. (a) Macroscopic image 
of three colloid ﬁ  lms. (b) Magniﬁ  ed view showing one fragment of a colloid ﬁ  lm.International Journal of Nanomedicine 2007:2(4) 794
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result in bright reﬂ  ectance rings being formed around the 
cytoplasmic membrane and their optical reﬂ  ectance proper-
ties being increased signiﬁ  cantly under confocal reﬂ  ectance 
microscopy. In contrast, the strong reﬂ  ectance signal from 
the bright scattering rings was not observed in our control 
labeling with a non-binding BSA conjugated gold nanopar-
ticles as the BSA were unable to target and bind to the cells 
and were therefore removed during the washing steps after 
the incubation.
Furthermore, our results have also demonstrated the 
possibility of exploiting the strong optical response of 
gold nanoparticles to transduce the molecular signals into 
observable optical signals and generate molecular contrast 
to image the expression of EGFR in cancer cells. The gold 
labeling pattern arising from the increased in reﬂ  ectance 
was able to provide a map of EGFR expression under con-
focal reﬂ  ectance microscopy. However, as the nucleus and 
other organelles in the cells are also generally reﬂ  ective 
(as depicted in Figure 4), we do note that the signal-to-
noise ratio achieved using such reﬂ  ective probe to image 
biomarker expression is generally lower than that achieved 
with ﬂ  uorescent probes. Nonetheless, the reﬂ  ectance signal 
from the gold nanoparticles probe should provide sufﬁ  ciently 
high contrast against intrinsic reﬂ  ectance signal in cells and 
tissue to map the biomarker expression under certain imag-
ing application where the use of ﬂ  uorescence regime is not 
possible such as in OCT.
As EGFR is differentially expressed in the two cell lines 
used in this study, we made use of this differential expres-
sion of EGFR to regulate the amount of gold nanoparticles 
attached to the cells and thus elicit an optical contrast to 
“illuminate” the cancer cells over normal cells. This form 
of discrimination for a possible early cancer detection 
strategy is based solely on their molecular changes in 
biomarker expression rather than consequential phenotypic 
changes. The differences in reﬂ  ectance intensity could 
potentially be detected by promising clinical optical mo-
dalities such as OCT or confocal endomicrosope working 
in the reﬂ  ectance mode. In practice, the EGFR expression 
is detected at all stages of carcinogenesis, from normal-
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early hyperplasia, dysplasia to invasive carcinoma (Kannan 
et al 1994; Shintani et al 1996) and it is elevated during the 
progression from hyperplasia to dysplasia and increases 
during progression from dysplasia to invasive carcinoma 
(Shin et al 1994), thus giving a spectrum of expression 
levels with disease progression. As the reﬂ  ectance signal 
depends on the level of EGFR expression, its intensity may 
further provide indications of the progression of diseases 
at the molecular level. However, we also observed hetero-
geneous labeling with the anti-EGFR gold nanoparticles 
on CNE2 cells (Figure 3c and 4d). This heterogeneity of 
protein expression in cell lines is common and has been 
described previously in the case of EGFR (Monaghan et al 
1990). Therefore, further studies need to be conducted to 
quantitatively relate the reﬂ  ectance signal from the gold 
nanoparticles attachment to the EGFR expression level in 
well-calibrated cell lines.
Although our in vitro results on cell lines seem promis-
ing, the use of gold nanoparticles in the same manner in vivo 
would warrant attention to the challenges in the way these 
nanoparticles could potentially elicit any body response and 
subsequently be eliminated from the body system with mini-
mal side effects after their diagnostic use. Previous studies 
by other groups have shown that these gold nanoparticles 
tend to be taken up by the cells through endocytosis as fast 
as 1 h into the incubation with gold nanoparticles (Connor 
et al 2005). In this case, the anti-EGFR binding to cell sur-
face EGFR could potentially provide a receptor-mediated 
endocytosis route for the gold nanoparticles. Connor and col-
leagues examined a series of gold nanoparticles for cellular 
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Figure 7 A 1 μm × 1 μm AFM image of the colloid ﬁ  lm, showing closely-packed morphology of the gold nanoparticles in the ﬁ  lm.International Journal of Nanomedicine 2007:2(4) 796
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uptake and acute cytotoxicity in human leukemia cells and 
found that despite being taken up into the cells, spherical 
gold nanoparticles with a variety of surface modiﬁ  ers were 
not inherently toxic to human cells (Connor et al 2005). 
Mukherjee et al have also shown that gold nanoparticles have 
no effect on gene expression or other global transcriptional 
pattern of human umbilical vein endothelial cells (HUVEC) 
(Mukherjee et al 2006).
Although tests on other forms of body response in terms 
of cellular adhesion effects, local biological effects or other 
systemic and remote effects have not been performed in this 
study, previous literatures have shown that colloidal gold 
nanoparticles is an inert material that can be injected to living 
animals without major complications. The small size of these 
particles enables them to extravasate out of the microcircula-
tion easily and diffuse through the interstitial compartments 
of tissue efﬁ  ciently. Without proper surface functionaliza-
tion, most of the circulating nanoparticles will be trapped by 
reticuloendothelial system in liver, kidney, spleen and lungs 
and may remain there and in other tissue for a long time 
without interfering with metabolism of cells, although a small 
amount of gold nanoparticles may be secreted to the bile or 
urine (Eghtedari et al 2003). Whilst metal poisoning is often 
associated with renal and hepatic toxicities, Mukherjee and 
colleagues have determined the effect of gold nanoparticles 
administration on liver and renal function on mice and found 
that there were no signiﬁ  cant differences between serum 
levels of creatinine, blood urea nitrogen, bilirubin alkaline 
phosphatase, alanine aminotransferase, and aspartate amino-
transferase between gold nanoparticles treated and untreated 
control animals after 7 days of administration, thus conclud-
ing minimal effect of gold nanoparticles in renal and hepatic 
functioning (Mukherjee et al 2005). Despite the fact that 
gold nanoparticles have been injected to many patients in the 
past to treat rheumatoid arthritis or to study the function of 
reticuloendothelial system based on the past three decades of 
literature, there are only a few, if any, reports on complications 
of intravenous gold injection (Gumpel 1974).
Apart from enhancing the molecular contrast of cancer 
biomarkers under reﬂ  ectance-mode imaging, gold nanopar-
ticles can also be closely packed to form a ﬁ  lm substrate to 
enhance the Raman signal of ﬂ  uid analytes. Figure 5 illus-
trates the typical structures of a gold particle ﬁ  lm fabricated 
using our deposition method. The detailed mechanism behind 
the formation of different regions in the deposited gold 
nanoparticle ﬁ  lms is currently being studied. Nevertheless, 
we stress that the different types of colloid regions are readily 
discernible under the microscope, and it is easy to identify 
and avoid the non-uniform colloid layers during a SERS 
measurement. Measurements have also showed that uniform 
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ﬁ  lms sized between 10 to 25 mm2 can easily be reproduced 
using our current fabrication technique. A large colloid layer 
certainly has the advantage of ease of identiﬁ  cation and 
localization under the microscope.
Figure 7 shows the typical AFM image of a uniformly 
coated region in the ﬁ  lms. As observed from the ﬁ  gure, it is 
difﬁ  cult to ascertain whether these islands are actually consist-
ing of closely-spaced gold nanoparticles or large aggregates 
due to the fact that the gold nanoparticles are too small to be 
resolved by the AFM tip. However, it is possible to “artiﬁ  -
cially” enhance the spatial resolution by digitally processing 
the image using a band-pass ﬁ  lter as described previously 
(Micheletto et al 1995). From the processed image, the separa-
tion between two closest particle centers was estimated to be 
about 17 nm ± 15 %, which is comparable to the diameter of 
the individual particles. This result together with the double-
peak feature seen in the UV-Vis spectrum in Figure 6 leads 
us to believe that the particles are closely-packed but physi-
cally separated. Thus, assuming a particle radius of 7.5 nm, 
the particle-to-particle separation of 17 nm can be translated 
to an interparticle distance of about 2 nm, which is close to 
the thickness of the adsorbed ion layer (0.5–1 nm) on the 
particle surface (Giersig and Mulvaney 1993), which in this 
case is the chloride ion. Note that in no case did we observe 
any interfering signal from this adsorbed ion layer.
The stability of the particle ﬁ  lms was tested by immersing 
in a 10 % salt solution for 2 weeks. No re-suspension of par-
ticles was observed. There was also no re-suspension when 
saliva was applied on it. Such a good stability of the ﬁ  lm is 
attributable to the strong electrostatic attraction between the 
negatively-charged particles and the underlying positively-
charged SuperFrost®Plus surface. We stress that our ﬁ  lms 
were assembled solely by the convection-induced particle 
ﬂ  ows in the wetting ﬁ  lm near the contact line of the drying 
droplet and not by the spontaneous electrostatic adsorption 
of particles on the solid surface as in the case of electrostatic 
self-assembly (Sastry 2002). This was conﬁ  rmed by immers-
ing a SuperFrost®Plus glass slide in a colloidal solution of 
gold nanoparticles for 2 days. No particle attachment was 
observed. Furthermore, no stable colloid ﬁ  lm can be formed 
if the gold suspension drop is dried on a normal microsope 
glass slide, which lacks the electrostatic layers. Films formed 
on these slides were either partially or completely removed 
upon rinsing with distilled water.
Typical SERS saliva spectra are shown in Figure 8. 
Three Raman peaks occurred at 670, 1079, and 1627 cm–1 
are characteristic of saliva specimens collected from cancer 
patients. Of these bands, special note must be given to that 
situated at 1627 cm–1, which were observed for 3 of the 5 saliva 
samples collected from the patients. This particular band was 
also observed in a previous Raman study of cancerous oral 
tissues (Ulas 1999). As to whether there is any correlation 
in the Raman signals at 1627 cm–1 between the saliva spec-
tra and those derived from the tissues is not known at the 
moment. Certainly, a comparison of SERS saliva spectra and 
the Raman spectra derived from matched oral tissues should 
provide an answer. This is currently being carried out in our 
lab. We are also unable to evaluate the applicability of using 
the saliva spectrum for cancer staging at this stage, owing to 
insufﬁ  cient samples. More samples are needed. The inconsis-
tency of SERS has also been noted in this study. The signal 
reproducibility of our ﬁ  lms is checked using Crystal Violet 
solution as test sample and found to be about 11% (data not 
shown). From further patient samples, we observe a sensitivity 
of the current technique in the range of around 70% ie,70% 
of the “abnormal” saliva shows abnormal peaks. However, 
none of the normal samples show these indicative peaks. We 
are currently working to develop a better SERS substrate 
consisting of periodic metallic nanostructures as opposed to 
the randomly-distributed nanoparticles ﬁ  lm employed in the 
current study. This should improve signal reproducibility, 
thereby rendering quantitative analysis of the absolute signal 
intensity possible. However, the results of this study show the 
potential of these simple gold nanoparticles ﬁ  lm for routine 
clinical diagnosis of oral cancer.
Conclusion
As cancer-associated biomarkers precede phenotypic mani-
festations of disease, there is a growing research interest in 
clinical molecular diagnostics for early cancer detection. 
Combining advances in biomedical optics and nanotech-
nology offers the opportunity to signiﬁ  cantly impact future 
strategies towards the detection and diagnosis cancer. This 
study demonstrates the potential of antibody conjugated gold 
nanoparticles to target and illuminate cancer cells under a 
reﬂ  ectance-based optical imaging system. In particular, we 
have shown that gold nanoparticles can provide an optical 
contrast to discriminate between cancerous and normal cells 
and their conjugation with antibodies also allows them to map 
the expression of relevant biomarkers for molecular imaging. 
Such molecular imaging has the potential to base disease 
detection on early molecular abnormalities before diseases 
become obvious with traditional imaging techniques. In ad-
dition, we have also demonstrated the use of SERS-active 
gold nanoparticle ﬁ  lms fabricated using a simple drop-dry 
approach in the chemical analysis of saliva. SERS spectra of International Journal of Nanomedicine 2007:2(4) 798
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saliva were obtained and shown to be differentiable between 
those acquired from normal individuals and oral cancer 
patients, thus showing promise of a simple SERS-based 
saliva assay for early diagnosis of oral cancer. All these may 
be translated to improved patient care by facilitating earlier 
cancer detection and phenotyping of tumors at a stage before 
debilitating or irreversible symptoms appear.
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